These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18348242)
21. Beyond antibodies: using biological principles to guide the development of next-generation protein therapeutics. Kariolis MS; Kapur S; Cochran JR Curr Opin Biotechnol; 2013 Dec; 24(6):1072-7. PubMed ID: 23587963 [TBL] [Abstract][Full Text] [Related]
22. Does the European pharmaceutical industry have a future? McKillop T Circulation; 2006 Feb; 113(5):f19-20. PubMed ID: 16468149 [No Abstract] [Full Text] [Related]
24. Three decades of human monoclonal antibodies: past, present and future developments. Steinitz M Hum Antibodies; 2009; 18(1-2):1-10. PubMed ID: 19478393 [TBL] [Abstract][Full Text] [Related]
25. Overhauling oversight--European drug legislation. Tsang L Nat Biotechnol; 2005 Sep; 23(9):1050-3. PubMed ID: 16151389 [TBL] [Abstract][Full Text] [Related]
29. DNA patent decision leaves questions for diagnostics. Harrison C Nat Rev Drug Discov; 2011 Aug; 10(9):650-1. PubMed ID: 21878971 [No Abstract] [Full Text] [Related]
30. Clinical use of intravenous immunoglobulins. Nydegger UE; Mohacsi PJ; Escher R; Morell A Vox Sang; 2000; 78 Suppl 2():191-5. PubMed ID: 10938951 [TBL] [Abstract][Full Text] [Related]
34. Flexible Biomanufacturing Processes that Address the Needs of the Future. Diel B; Manzke C; Peuker T Adv Biochem Eng Biotechnol; 2014; 138():207-37. PubMed ID: 23949696 [TBL] [Abstract][Full Text] [Related]
35. Antibodies in diagnostics - from immunoassays to protein chips. Borrebaeck CA Immunol Today; 2000 Aug; 21(8):379-82. PubMed ID: 10916140 [TBL] [Abstract][Full Text] [Related]
36. Editorial: Biotechnology in Korea--the next generation growth engine. Lee SY Biotechnol J; 2008 May; 3(5):562-3. PubMed ID: 18481356 [No Abstract] [Full Text] [Related]
37. The next generation? Nat Biotechnol; 2006 Nov; 24(11):1300. PubMed ID: 17093454 [TBL] [Abstract][Full Text] [Related]
38. Divining the path to a successful European exit. Buch HK; Gustafsson AC; Drvota V; Sundberg CJ Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008 [No Abstract] [Full Text] [Related]
39. Growing pains for biopharmaceuticals. Ashton G Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578 [No Abstract] [Full Text] [Related]
40. Global antibody development trends. Reichert JM MAbs; 2009; 1(1):86-7. PubMed ID: 20046578 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]